Lpath Humanizes Its Anti-S1P Antibody Sphingomab™

News   Jun 13, 2006

 
Lpath Humanizes Its Anti-S1P Antibody Sphingomab™
 
 
 

RELATED ARTICLES

Bad Teeth Put to Good Use

News

Researchers analysing the teeth of Britons from the Iron Age to the modern day have unlocked the potential for using proteins in tooth tartar to reveal what our ancestors ate.

READ MORE

Working Together Helps Phage Overcome CRISPR

News

Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.

READ MORE

Study in Mouse Model of Autism Finds Mother's Microbiome Determines Risk

News

The microbiome is the collection of microorganisms, such as bacteria, that naturally live inside us. New research in a mouse model suggests the microbiome determines autism risk.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy